C Valenzuela, SE Torrisi, N Kahn, M Quaresma… - Respiratory …, 2020 - Springer
The approvals of nintedanib and pirfenidone changed the treatment paradigm in idiopathic
pulmonary fibrosis (IPF), and increased our understanding of the underlying disease …